550 related articles for article (PubMed ID: 17414713)
1. Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo.
Poncelet AJ; Vercruysse J; Saliez A; Gianello P
Transplantation; 2007 Mar; 83(6):783-90. PubMed ID: 17414713
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of humoral response to allogeneic porcine mesenchymal stem cell with 12 days of tacrolimus.
Poncelet AJ; Nizet Y; Vercruysse J; Hiel AL; Saliez A; Gianello P
Transplantation; 2008 Dec; 86(11):1586-95. PubMed ID: 19077894
[TBL] [Abstract][Full Text] [Related]
3. Human mesenchymal stem cells inhibit antibody production induced in vitro by allostimulation.
Comoli P; Ginevri F; Maccario R; Avanzini MA; Marconi M; Groff A; Cometa A; Cioni M; Porretti L; Barberi W; Frassoni F; Locatelli F
Nephrol Dial Transplant; 2008 Apr; 23(4):1196-202. PubMed ID: 18029377
[TBL] [Abstract][Full Text] [Related]
4. T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression.
Klyushnenkova E; Mosca JD; Zernetkina V; Majumdar MK; Beggs KJ; Simonetti DW; Deans RJ; McIntosh KR
J Biomed Sci; 2005; 12(1):47-57. PubMed ID: 15864738
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G.
Nasef A; Mathieu N; Chapel A; Frick J; François S; Mazurier C; Boutarfa A; Bouchet S; Gorin NC; Thierry D; Fouillard L
Transplantation; 2007 Jul; 84(2):231-7. PubMed ID: 17667815
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia.
Ishikane S; Ohnishi S; Yamahara K; Sada M; Harada K; Mishima K; Iwasaki K; Fujiwara M; Kitamura S; Nagaya N; Ikeda T
Stem Cells; 2008 Oct; 26(10):2625-33. PubMed ID: 18669910
[TBL] [Abstract][Full Text] [Related]
8. Administration of donor-derived mesenchymal stem cells can prolong the survival of rat cardiac allograft.
Zhou HP; Yi DH; Yu SQ; Sun GC; Cui Q; Zhu HL; Liu JC; Zhang JZ; Wu TJ
Transplant Proc; 2006 Nov; 38(9):3046-51. PubMed ID: 17112896
[TBL] [Abstract][Full Text] [Related]
9. Genetically-modified pig mesenchymal stromal cells: xenoantigenicity and effect on human T-cell xenoresponses.
Ezzelarab M; Ezzelarab C; Wilhite T; Kumar G; Hara H; Ayares D; Cooper DK
Xenotransplantation; 2011; 18(3):183-95. PubMed ID: 21696448
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells prolong composite tissue allotransplant survival in a swine model.
Kuo YR; Goto S; Shih HS; Wang FS; Lin CC; Wang CT; Huang EY; Chen CL; Wei FC; Zheng XX; Lee WP
Transplantation; 2009 Jun; 87(12):1769-77. PubMed ID: 19543052
[TBL] [Abstract][Full Text] [Related]
11. Immunological properties of umbilical cord blood-derived mesenchymal stromal cells.
Oh W; Kim DS; Yang YS; Lee JK
Cell Immunol; 2008 Feb; 251(2):116-23. PubMed ID: 18495100
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro.
Bocelli-Tyndall C; Bracci L; Spagnoli G; Braccini A; Bouchenaki M; Ceredig R; Pistoia V; Martin I; Tyndall A
Rheumatology (Oxford); 2007 Mar; 46(3):403-8. PubMed ID: 16920750
[TBL] [Abstract][Full Text] [Related]
13. Human bone marrow mesenchymal stem cells and chondrocytes promote and/or suppress the in vitro proliferation of lymphocytes stimulated by interleukins 2, 7 and 15.
Bocelli-Tyndall C; Bracci L; Schaeren S; Feder-Mengus C; Barbero A; Tyndall A; Spagnoli GC
Ann Rheum Dis; 2009 Aug; 68(8):1352-9. PubMed ID: 18647856
[TBL] [Abstract][Full Text] [Related]
14. Immune properties of human umbilical cord Wharton's jelly-derived cells.
Weiss ML; Anderson C; Medicetty S; Seshareddy KB; Weiss RJ; VanderWerff I; Troyer D; McIntosh KR
Stem Cells; 2008 Nov; 26(11):2865-74. PubMed ID: 18703664
[TBL] [Abstract][Full Text] [Related]
15. The immunobiological development of human bone marrow mesenchymal stem cells in the course of neuronal differentiation.
Liu CT; Yang YJ; Yin F; Wang X; Yu XH; Wang QH; Wang XL; Xie M
Cell Immunol; 2006 Nov; 244(1):19-32. PubMed ID: 17448455
[TBL] [Abstract][Full Text] [Related]
16. Characterization of EGFP-labeled mesenchymal stem cells and redistribution of allogeneic cells after subcutaneous implantation.
Duan X; Yang L; Dong S; Xin R; Chen G; Guo L
Arch Orthop Trauma Surg; 2008 Jul; 128(7):751-9. PubMed ID: 18265994
[TBL] [Abstract][Full Text] [Related]
17. Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis.
Augello A; Tasso R; Negrini SM; Cancedda R; Pennesi G
Arthritis Rheum; 2007 Apr; 56(4):1175-86. PubMed ID: 17393437
[TBL] [Abstract][Full Text] [Related]
18. Histocompatibility testing of cultivated human bone marrow stromal cells - a promising step towards pre-clinical screening for allogeneic stem cell therapy.
Koppula PR; Chelluri LK; Polisetti N; Vemuganti GK
Cell Immunol; 2009; 259(1):61-5. PubMed ID: 19577229
[TBL] [Abstract][Full Text] [Related]
19. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation.
Tse WT; Pendleton JD; Beyer WM; Egalka MC; Guinan EC
Transplantation; 2003 Feb; 75(3):389-97. PubMed ID: 12589164
[TBL] [Abstract][Full Text] [Related]
20. Functional and phenotypic alteration of intrasplenic lymphocytes affected by mesenchymal stem cells in a murine allosplenocyte transfusion model.
Li H; Guo ZK; Li XS; Hou CM; Tang PH; Mao N
Cell Transplant; 2007; 16(1):85-95. PubMed ID: 17436858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
